122 related articles for article (PubMed ID: 2394085)
1. The effect of calcitonin gene-related peptide (CGRP) on human forearm blood flow.
Jernbeck J; Edner M; Dalsgaard CJ; Pernow B
Clin Physiol; 1990 Jul; 10(4):335-43. PubMed ID: 2394085
[TBL] [Abstract][Full Text] [Related]
2. Vasodilating actions of calcitonin gene-related peptide in normal man: comparison with atrial natriuretic peptide.
Ando K; Ito Y; Ogata E; Fujita T
Am Heart J; 1992 Jan; 123(1):111-6. PubMed ID: 1530893
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography.
Vanmolkot FH; de Hoon JN
Br J Clin Pharmacol; 2005 Apr; 59(4):387-97. PubMed ID: 15801933
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model.
Vanmolkot FH; Van der Schueren BJ; de Hoon JN
Clin Pharmacol Ther; 2006 Mar; 79(3):263-73. PubMed ID: 16513450
[TBL] [Abstract][Full Text] [Related]
6. Substance P and calcitonin gene-related peptide in the chicken skin: distribution and cardiovascular effects.
Sann H; Friedrich R; Pierau FK
Neuropeptides; 1996 Jun; 30(3):273-81. PubMed ID: 8819151
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels.
Cockcroft JR; Noon JP; Gardner-Medwin J; Bennett T
Br J Clin Pharmacol; 1997 Jul; 44(1):57-60. PubMed ID: 9241097
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin gene-related peptide (CGRP) causes redistribution of blood flow in humans.
Jäger K; Muench R; Seifert H; Beglinger C; Bollinger A; Fischer JA
Eur J Clin Pharmacol; 1990; 39(5):491-4. PubMed ID: 2076743
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin gene-related peptide8-37 antagonizes capsaicin-induced vasodilation in the skin: evaluation of a human in vivo pharmacodynamic model.
Van der Schueren BJ; Rogiers A; Vanmolkot FH; Van Hecken A; Depré M; Kane SA; De Lepeleire I; Sinclair SR; de Hoon JN
J Pharmacol Exp Ther; 2008 Apr; 325(1):248-55. PubMed ID: 18216286
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin gene-related peptide: exploring its vasodilating mechanism of action in humans.
de Hoon JN; Pickkers P; Smits P; Struijker-Boudier HA; Van Bortel LM
Clin Pharmacol Ther; 2003 Apr; 73(4):312-21. PubMed ID: 12709721
[TBL] [Abstract][Full Text] [Related]
11. Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms.
McEwan JR; Benjamin N; Larkin S; Fuller RW; Dollery CT; MacIntyre I
Circulation; 1988 May; 77(5):1072-80. PubMed ID: 2452035
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin gene-related peptide is a potent intestinal, but not gastric, vasodilator in conscious dogs.
Nakamura T; Naruse S; Ozaki T; Kumada K
Regul Pept; 1996 Sep; 65(3):211-7. PubMed ID: 8897644
[TBL] [Abstract][Full Text] [Related]
13. Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability.
Newby DE; Sciberras DG; Mendel CM; Gertz BJ; Boon NA; Webb DJ
Br J Clin Pharmacol; 1997 May; 43(5):493-9. PubMed ID: 9159564
[TBL] [Abstract][Full Text] [Related]
14. Carotid blood flow distribution, haemodynamics and inotropic responses following calcitonin gene-related peptide in the pig.
Van Gelderen EM; Du XY; Schoemaker RG; Saxena PR
Eur J Pharmacol; 1995 Sep; 284(1-2):51-60. PubMed ID: 8549636
[TBL] [Abstract][Full Text] [Related]
15. Interaction of human adrenomedullin 13-52 with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster.
Hall JM; Siney L; Lippton H; Hyman A; Kang-Chang J; Brain SD
Br J Pharmacol; 1995 Feb; 114(3):592-7. PubMed ID: 7735685
[TBL] [Abstract][Full Text] [Related]
16. Synergistic internal carotid vasodilator effects of human alpha-calcitonin gene-related peptide and nimodipine in conscious rats.
Gardiner SM; Compton AM; Bennett T; Kemp PA; Ney U
Br J Pharmacol; 1990 Apr; 99(4):830-4. PubMed ID: 2193690
[TBL] [Abstract][Full Text] [Related]
17. Regional haemodynamic effects of prolonged infusions of human alpha-calcitonin gene-related peptide in conscious, Long Evans rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 Jun; 103(2):1509-14. PubMed ID: 1884105
[TBL] [Abstract][Full Text] [Related]
18. CGRP-mediated changes in segmental resistances in the canine forelimb.
Dobbins DE
Microcirc Endothelium Lymphatics; 1990 Dec; 6(6):465-81. PubMed ID: 2099388
[TBL] [Abstract][Full Text] [Related]
19. Plethysmographic evaluation of the vascular effects of human calcitonin gene-related peptide in man.
Gennari C; Nami R; Pecchi S; De Franco V; Panza F; Pavese G
Angiology; 1991 Jun; 42(6):462-7. PubMed ID: 2042794
[TBL] [Abstract][Full Text] [Related]
20. Vasodilator responses in the forearm skin of patients with insulin-dependent diabetes mellitus.
Khan F; Cohen RA; Ruderman NB; Chipkin SR; Coffman JD
Vasc Med; 1996; 1(3):187-93. PubMed ID: 9546937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
